期刊文献+

幽门螺杆菌热休克蛋白A亚单位基因工程菌的发酵 被引量:4

Fermentation of Gene Engineering E . coil of Helicobacter pylori Heat Shock Protein A
暂未订购
导出
摘要 目的 研究幽门螺杆菌热休克蛋白A亚单位(HspA)基因工程菌的发酵工艺。方法 通过不同培 养基、不同葡萄糖浓度、不同溶氧条件、补料与非补料对幽门螺杆菌热休克蛋白A亚单位基因工程菌的菌体生长与 外源蛋白表达量的影响的比较,确定其较为合适的培养条件。结果 多批实验证明,菌体单产可达42g/L,目的蛋 白的表达率为38.5%。结论 此发酵工艺可以提高HspA基因工程菌菌体的得率和目的蛋白的表达。 Objective To investigate fermentation conditions of gene engineering E. coli strain for expression of Helicobacter pylori heat-shock protein A( HspA). Methods The influences of media, glucose concentration, dissolved oxygen and fed-batch on the growth of gene engineering E. coli strain and expression of Hsp A were compared, and, on the basis of this, the optimal fermentation conditions were studied. Results Under the optimal fermentation condition, the cell output and expression rate of Hsp A reached 42g/L and 38. 5% respectively. Conclusion Both the recovery rate of gene engineering E. coli strain and expression level of Hsp A were improved under the fermentation condition.
出处 《中国生物制品学杂志》 CAS CSCD 2001年第2期84-86,共3页 Chinese Journal of Biologicals
基金 国家"九五"重点科技攻关项目(96-901-01-54)。
关键词 幽门螺杆菌 热休克蛋白A亚单位 大肠杆菌 发酵工艺 Helicobacter pylori Heat Shock Protein E. coli Fermentation
  • 相关文献

参考文献4

二级参考文献5

共引文献7

同被引文献28

  • 1颜子颖 王海林(译).精编分子生物学实验指南(第1版)[M].北京:科学出版社,1998.123-126.
  • 2[1]Luzza F, Maletta M, Imeneo M, et al. Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients[J]. Am J Gastroenterol,1995,90(10):1 820-1 823.
  • 3[10]Blanchard TG, Czinn SJ, Nedrud JG, et al . Host response and vaccine development to Helicobaeter pylori infection[J]. Curr Top Microbiol Immunol,1999,241(2):181-213.
  • 4[11]Labigne A, Reuse HD. Determinants of Helicobacter pylori pathogenicit1y[J]. Infect Agents Dis,1996,5(4):191-202.
  • 5Blaser M J, Parsonnet J. Parasitisn by the slow bacterium Helicdacterpylori leads to alter gastric homestasis and neoplasia. J Clin Invest,1994,94:4-8.
  • 6Patra AK, Mukhopadhyay R, Mukhija R, et al. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Protein Expr Purif, 2000,18(2):182-192.
  • 7Ghiara P, Marchetti M, Blaser M J, et al. Role of Helicobacter pylori virulence factors vacuolating cytotoxin, CagA and urease in a mousemodel of disease. Infect Immun,1995, 63: 4154-4160.
  • 8Marchetti M, Arico B, Burroni D,et al. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science, 1995, 267:1655-1658.
  • 9Czinn S J, Cai A,Nedrud J G. Protection of germ- free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine ,1993,11, 637-642.
  • 10Glupczynski Y, Burette A, Goossens H, et al. Effect of antimicrobialtherapy on the specific serological response to Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis,1992, 11:583-588.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部